views
Asthma
and COPD Drugs Market Highlights
The Asthma and COPD Drugs Market is
projected to reach USD 34,374.23 Million by 2030 at 4.20% CAGR during the
forecast period 2022-2030. Asthma is a type of inflammatory disease that
affects the lungs and makes breathing difficult. It is one of the common
chronic conditions affecting many people across the globe. COPD or chronic
obstructive pulmonary disease is an umbrella term used for a group of
respiratory diseases such as emphysema and chronic bronchitis.
Regional Analysis
Global asthma and COPD drugs market insights,
based on region, has been divided into the Americas, Europe, Asia-Pacific, and
the Middle East & Africa.
The Americas are likely to dominate
global asthma and COPD drugs market. This can be attributed to the rising
patient population suffering from asthma and COPD in the region. According to
the American Academy of Allergy Asthma & Immunology, in 2016, approximately
8.3% of children in the US had asthma. Moreover, the rising health expenditure
per person and increasing demand for advanced treatment options are also
expected to drive market growth.
The European market for asthma and COPD
drugs is expected to be the second largest during the review period. The
growing awareness of asthma and COPD in Europe is expected to boost the growth
of the regional market. For instance, in April 2017, the “United Action for
Allergy and Asthma” was launched in Europe to raise awareness regarding asthma
in the continent. Additionally, the prevalence of asthma and COPD is also
increasing in Europe, which is also fuelling market growth.
Asia-Pacific is estimated to be the
fastest-growing market owing to the rising awareness regarding COPD and asthma
in the region. For instance, Koninklijke Philips launched a campaign in May
2019, for raising awareness of asthma in India on World Asthma Day. Moreover, a
high prevalence of asthma and COPD is also positively affecting the market
growth.
The
market in the Middle East & Africa is expected to witness steady growth due
to the rising patient population suffering from asthma and COPD in the Middle
Eastern countries.
Segment Analysis
The Global Asthma and COPD Drugs Market have been
segmented by disease, product, route of administration, and distribution
channel. The market, based on disease, has been bifurcated into asthma and
COPD.
Based on product, asthma and COPD drugs market trends
has been segregated into long-term asthma control medications and quick-relief
medications. The long-term asthma control medications are further segmented
into combination drugs, anticholinergics, inhaled corticosteroids, long-acting
beta-agonists, theophylline, and others. The combination drugs are further
segregated into Seretide/Advair, Symbicort, Relvar/Breo Ellipta, Flutiform,
Dulera, and others. Anticholinergics is further sub-segmented into Spiriva and
others. Inhaled corticosteroids are further segmented into Pulmicort, Flovent,
Qvar, and others.
The quick-relief medications have been
further segmented into short-acting beta-agonists, oral & intravenous
corticosteroids, ipratropium bromide (Atrovent), and others. Short-acting
beta-agonists have been further segregated into Proair and Ventolin.
Global asthma and COPD drugs market,
based on the route of administration, has been segmented into oral, inhaled,
and others. Based on the distribution channels, global asthma and COPD drugs
market has been segmented into retail pharmacies, hospital pharmacies, and
online pharmacies.
Key
Players
The
Global Asthma and COPD Drugs Market Players - GlaxoSmithKline plc (UK),
AstraZeneca (UK), Boehringer Ingelheim International GmbH (Germany), and Chiesi
Farmaceutici SpA (Italy).
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com